Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 1.05 |   |
Earnings Per Share | -$1.02 |   |
Price To Sales Ratio | 4.92 |   |
Price To Book Ratio | 3.06 |   |
Price To Tangible Book Ratio | 3.52 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 91.3M |   |
Float (MRQ) | 70.21% |   |
Shares Outstanding (MRQ) | 101.4M |   |
Short Interest as a % of Float (MRQ) | 3.50% |   |
Shares Held By Institutions (MRQ) | 33.5M |   |
Margins | Industry Range | |
---|---|---|
Sales | $68.8M |   |
Gross Margin | 49.54% |   |
Net Profit Margin | -94.06% |   |
EBIT Margin | -268.64% |   |
EBITDA Margin | -258.76% |   |
Operating Margins | -268.64% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 3.43 |   |
Quick Ratio (MRQ) | 3.33 |   |
Total Debt/Equity Ratio (MRQ) | 68.99 |   |
Debt/Common Equity Ratio (MRQ) | 68.99 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -62.29% |   |
Return on Assets | -20.13% |   |
Asset Turnover | 0.21 |   |
Receivables Turnover | 2.74 |   |
Inventory Turnover | 3.65 |   |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | 23.44% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*FBIO does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%